{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:53:38Z","timestamp":1790538818327,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/nrgastro.2009.87","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T10:39:02Z","timestamp":1246617542000},"page":"433-436","source":"Crossref","is-referenced-by-count":34,"title":["Hepatosplenic T-cell lymphoma in a patient with Crohn's disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Florian","family":"Beigel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"J\u00fcrgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Tillack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"G\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ochsenk\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrgastro200987_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","volume":"146","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn, W. J. et al. Adalimumab induction therapy for Crohn's disease previously treated with infliximab: a randomized trial. Ann. Intern. Med. 146, 829\u2013838 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro200987_CR2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","volume":"75","author":"JP Farcet","year":"1990","unstructured":"Farcet, J. P. et al. Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 75, 2213\u20132219 (1990).","journal-title":"Blood"},{"key":"BFnrgastro200987_CR3","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe, E. S. et al. (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (IARC, Lyon, 2001)."},{"key":"BFnrgastro200987_CR4","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1182\/blood-2002-09-2908","volume":"101","author":"L Krenacs","year":"2003","unstructured":"Krenacs, L. et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. Blood 101, 3590\u20133593 (2003).","journal-title":"Blood"},{"key":"BFnrgastro200987_CR5","first-page":"1453","volume":"10","author":"P Jonveaux","year":"1996","unstructured":"Jonveaux, P., Daniel, M. T., Martel, V., Maarek, O. & Berger, R. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma\/delta lymphoma. Leukemia 10, 1453\u20131455 (1996).","journal-title":"Leukemia"},{"key":"BFnrgastro200987_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2559.2000.00804.x","volume":"36","author":"K Ohshima","year":"2000","unstructured":"Ohshima, K. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma: relation to Epstein\u2013Barr virus and activated cytotoxic molecules. Histopathology 36, 127\u2013135 (2000).","journal-title":"Histopathology"},{"key":"BFnrgastro200987_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/ibd.20169","volume":"13","author":"JR Rosh","year":"2007","unstructured":"Rosh, J. R., Gross, T., Mamula, P., Griffiths, A. & Hyams, J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm. Bowel Dis. 13, 1024\u20131030 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro200987_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/gut.2008.163279","volume":"57","author":"M Shale","year":"2008","unstructured":"Shale, M., Kanfer, E., Panaccione R. & Ghosh, S. Hepatosplenic T-cell lymphoma in inflammatory bowel disease. Gut 57, 1639\u20131641 (2008).","journal-title":"Gut"},{"key":"BFnrgastro200987_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/gut.2005.090464","volume":"56","author":"J Mudter","year":"2007","unstructured":"Mudter, J. & Neurath, M. F. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56, 293\u2013303 (2007).","journal-title":"Gut"},{"key":"BFnrgastro200987_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer, S. B. et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359, 1541\u20131549 (2002).","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"BFnrgastro200987_CR11","first-page":"A116","volume":"134","author":"L Beaugerie","year":"2008","unstructured":"Beaugerie, L. et al. Excess risk of lymphoproliferative disorders (LPD) in inflammatory bowel diseases (IBD): interim results of the CESAME cohort. Gastroenterology 134 (Suppl. 1), A116\u2013A117 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro200987_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/gut.2004.049460","volume":"54","author":"A Kandiel","year":"2005","unstructured":"Kandiel, A., Fraser, A. G., Korelitz, B. I., Brensinger, C. & Lewis, J. D. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54, 1121\u20131125 (2005).","journal-title":"Gut"},{"key":"BFnrgastro200987_CR13","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","volume":"134","author":"G van Assche","year":"2008","unstructured":"van Assche, G. et al. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 134, 1861\u20131868 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro200987_CR14","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj, K. et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 102, 4261\u20134269 (2003).","journal-title":"Blood"},{"key":"BFnrgastro200987_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1365-2141.2000.02129.x","volume":"110","author":"D Aldinucci","year":"2000","unstructured":"Aldinucci, D. et al. In vitro and in vivo effects of 2\u2032-deoxycoformycin (Pentostatin) on tumour cells from human \u03b3\u03b4+ T-cell malignancies. Br. J. Haematol. 110, 188\u2013196 (2000).","journal-title":"Br. J. Haematol."},{"key":"BFnrgastro200987_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","volume":"76","author":"S Mittal","year":"2006","unstructured":"Mittal, S., Milner, B. J., Johnston, P. W. & Culligan, D. J. A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab. Eur. J. Haematol. 76, 531\u2013534 (2006).","journal-title":"Eur. J. Haematol."},{"key":"BFnrgastro200987_CR17","first-page":"1","volume":"29","author":"MR Humphreys","year":"2008","unstructured":"Humphreys, M. R., Cino, M., Quirt, I., Barth, D. & Kukreti, V. Long-term survival in two patients with hepatosplenic T-cell lymphoma treated with interferon-\u03b1. Leuk. Lymphoma 29, 1\u20134 (2008).","journal-title":"Leuk. Lymphoma"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2009.87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2009.87","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2009.87.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:40:00Z","timestamp":1684467600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2009.87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFnrgastro200987"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2009.87","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}